Open | - |
Close | - |
Volume / Avg. | 0 / 2.109M |
Day Range | - - - |
52 Wk Range | 0.520 - 29.040 |
Market Cap | $3.915M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 39 |
Short Interest | % |
Days to Cover | 1 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of SenesTech (NASDAQ: SNES) through any online brokerage.
Other companies in SenesTech’s space includes: Cingulate (NASDAQ:CING), Processa Pharma (NASDAQ:PCSA), Titan Pharma (NASDAQ:TTNP), 60 Degrees (NASDAQ:SXTP) and MyMD Pharmaceuticals (NASDAQ:MYMD).
The latest price target for SenesTech (NASDAQ: SNES) was reported by HC Wainwright & Co. on Thursday, December 28, 2023. The analyst firm set a price target for 3.50 expecting SNES to rise to within 12 months (a possible 359.92% upside). 3 analyst firms have reported ratings in the last year.
The stock price for SenesTech (NASDAQ: SNES) is $0.761 last updated March 18, 2024 at 4:26 PM EDT.
There are no upcoming dividends for SenesTech.
SenesTech’s Q1 earnings are confirmed for Thursday, May 9, 2024.
There is no upcoming split for SenesTech.
SenesTech is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.